Supernus Pharmaceuticals (SUPN) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $37.88, -4.27% vs the prior close of $39.57.
- Volume 1.44M shares, 2.1x its 50-day average (heavy).
- New SEC filings: 8-K (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
SUPN slides 4.3% to $37.88, a 52-week low on 2.1x normal volume. Closed at $37.88, -4.27% vs the prior close of $39.57. Day range $37.54β$39.49, opened at $39.19.
SUPN daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β SUPN slides 4.3% to $37.88, a 52-week low on 2.1x normal volume
- Closed at $37.88, -4.27% vs the prior close of $39.57. Day range $37.54β$39.49, opened at $39.19.
- Volume was 1.44M shares, 2.1x its 50-day average of 678.95K β unusually heavy trading.
- Price is -13.6% vs its 50-day average ($43.83) and -20.7% vs its 200-day average ($47.76).
- 52-week range $37.54β$59.68; today's close sits at 2% of that range, 36.5% below the 52-week high.
- That makes 4 straight losses.
Oct 15, 2026 β SUPN dips 1.5% to $39.57, a 52-week low, 3 down days in a row
- Closed at $39.57, -1.52% vs the prior close of $40.18. Day range $39.36β$41.31, opened at $40.21.
- Volume was 1.01M shares, 1.5x its 50-day average of 692.12K.
- Price is -10.1% vs its 50-day average ($44.01) and -17.2% vs its 200-day average ($47.82).
- 52-week range $39.36β$59.68; today's close sits at 1% of that range, 33.7% below the 52-week high.
- That makes 3 straight losses.
- SEC filings that day: 8-K.
Oct 14, 2026 β SUPN slides 4.4% to $40.18, a 52-week low
- Closed at $40.18, -4.36% vs the prior close of $42.01. Day range $39.97β$43.26, opened at $41.93.
- Volume was 906.70K shares, 1.2x its 50-day average of 748.10K.
- Price is -9.0% vs its 50-day average ($44.16) and -16.1% vs its 200-day average ($47.88).
- 52-week range $39.97β$59.68; today's close sits at 1% of that range, 32.7% below the 52-week high.
Oct 13, 2026 β SUPN dips 1.9% to $42.01
- Closed at $42.01, -1.87% vs the prior close of $42.81. Day range $41.71β$43.29, opened at $42.94.
- Volume was 1.20M shares, 1.5x its 50-day average of 814.53K.
- Price is -5.0% vs its 50-day average ($44.22) and -12.4% vs its 200-day average ($47.93).
- 52-week range $40.51β$59.68; today's close sits at 8% of that range, 29.6% below the 52-week high.
Oct 12, 2026 β SUPN rises 0.3% to $42.81
- Closed at $42.81, +0.33% vs the prior close of $42.67. Day range $41.90β$43.20, opened at $42.67.
- Volume was 914.60K shares, 1.1x its 50-day average of 807.71K.
- Price is -3.4% vs its 50-day average ($44.30) and -10.8% vs its 200-day average ($47.98).
- 52-week range $40.51β$59.68; today's close sits at 12% of that range, 28.3% below the 52-week high.
Oct 9, 2026 β SUPN rises 1.3% to $42.67
- Closed at $42.67, +1.26% vs the prior close of $42.14. Day range $42.15β$43.14, opened at $42.18.
- Volume was 643.80K shares, 0.8x its 50-day average of 804.17K.
- Price is -3.8% vs its 50-day average ($44.33) and -11.2% vs its 200-day average ($48.03).
- 52-week range $40.51β$59.68; today's close sits at 11% of that range, 28.5% below the 52-week high.
Oct 8, 2026 β SUPN dips 2.1% to $42.14
- Closed at $42.14, -2.11% vs the prior close of $43.05. Day range $41.14β$43.41, opened at $42.41.
- Volume was 684.20K shares, 0.9x its 50-day average of 800.93K.
- Price is -5.1% vs its 50-day average ($44.39) and -12.3% vs its 200-day average ($48.07).
- 52-week range $40.51β$59.68; today's close sits at 9% of that range, 29.4% below the 52-week high.
Oct 7, 2026 β SUPN rises 0.5% to $43.05, 4 up days in a row
- Closed at $43.05, +0.51% vs the prior close of $42.83. Day range $42.24β$43.38, opened at $42.24.
- Volume was 571.00K shares, 0.7x its 50-day average of 800.27K.
- Price is -3.2% vs its 50-day average ($44.48) and -10.5% vs its 200-day average ($48.12).
- 52-week range $40.51β$59.68; today's close sits at 13% of that range, 27.9% below the 52-week high.
- That makes 4 straight gains.
Oct 6, 2026 β SUPN ends flat (+0.2%) to $42.83, 3 up days in a row
- Closed at $42.83, +0.16% vs the prior close of $42.76. Day range $41.40β$43.12, opened at $42.86.
- Volume was 748.30K shares, 0.9x its 50-day average of 795.77K.
- Price is -3.9% vs its 50-day average ($44.58) and -11.0% vs its 200-day average ($48.15).
- 52-week range $40.51β$59.68; today's close sits at 12% of that range, 28.2% below the 52-week high.
- That makes 3 straight gains.
Oct 5, 2026 β SUPN rises 0.9% to $42.76
- Closed at $42.76, +0.90% vs the prior close of $42.38. Day range $42.38β$43.20, opened at $42.38.
- Volume was 1.29M shares, 1.7x its 50-day average of 780.44K.
- Price is -4.3% vs its 50-day average ($44.66) and -11.2% vs its 200-day average ($48.18).
- 52-week range $40.51β$59.68; today's close sits at 12% of that range, 28.4% below the 52-week high.
Oct 2, 2026 β SUPN rises 0.5% to $42.38
- Closed at $42.38, +0.47% vs the prior close of $42.18. Day range $41.88β$43.15, opened at $42.47.
- Volume was 739.80K shares, 1.0x its 50-day average of 774.91K.
- Price is -5.2% vs its 50-day average ($44.73) and -12.1% vs its 200-day average ($48.21).
- 52-week range $40.51β$59.68; today's close sits at 10% of that range, 29.0% below the 52-week high.
SUPN latest news & SEC filings
Every SEC filing by or about SUPN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 5.07 β Reported shareholder vote results.
Oct 6, 2026 Β· Form DEFA14A β Additional proxy materials
Additional proxy materials
Sep 11, 2026 Β· Form DEFM14A β DEFM14A filing
DEFM14A filing
Aug 14, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 14, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 14, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 14, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 14, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 6, 2026 Β· Form SCHEDULE 13G/A β Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 3, 2026 Β· Form DEFA14A β Additional proxy materials
Additional proxy materials
Aug 3, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 8.01 β Reported other events the company considers important.
Things to know before you trade SUPN
- Last results release: Aug 3, 2026 (8-K Item 2.02). Previous ones: Jul 22, 2026, May 5, 2026, Apr 22, 2026. Based on that rhythm, the next report is likely around Nov 2, 2026 β an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.72% (largest 4.5%).
- Liquidity: about 779.14K shares (β$29.51M) trade per day on average.
- 52-week position: $37.88 vs a range of $37.54β$59.68 (2% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Padmanabh P. Bhatt sold 412 shares on Mar 18, 2026.
- Latest filings: 8-K Oct 15, 2026; 8-K Aug 3, 2026; 8-K Aug 3, 2026.
- Share count: 58.13M shares outstanding (Jul 28, 2026), +3.7% vs a year earlier.
- Listing: Nasdaq Β· industry: Pharmaceutical Preparations.
SUPN market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 39.19 | 39.49 | 37.54 | 37.88 | 1.44M |
| Oct 15, 2026 | 40.21 | 41.31 | 39.36 | 39.57 | 1.01M |
| Oct 14, 2026 | 41.93 | 43.26 | 39.97 | 40.18 | 906.70K |
| Oct 13, 2026 | 42.94 | 43.29 | 41.71 | 42.01 | 1.20M |
| Oct 12, 2026 | 42.67 | 43.20 | 41.90 | 42.81 | 914.60K |
| Oct 9, 2026 | 42.18 | 43.14 | 42.15 | 42.67 | 643.80K |
| Oct 8, 2026 | 42.41 | 43.41 | 41.14 | 42.14 | 684.20K |
| Oct 7, 2026 | 42.24 | 43.38 | 42.24 | 43.05 | 571.00K |
| Oct 6, 2026 | 42.86 | 43.12 | 41.40 | 42.83 | 748.30K |
| Oct 5, 2026 | 42.38 | 43.20 | 42.38 | 42.76 | 1.29M |
| Oct 2, 2026 | 42.47 | 43.15 | 41.88 | 42.38 | 739.80K |
| Oct 1, 2026 | 43.21 | 43.69 | 42.15 | 42.18 | 424.60K |
| Sep 30, 2026 | 44.03 | 44.18 | 43.03 | 43.04 | 685.60K |
| Sep 29, 2026 | 44.39 | 44.93 | 43.20 | 43.97 | 551.60K |
| Sep 28, 2026 | 42.59 | 44.61 | 42.38 | 44.60 | 728.10K |
| Sep 25, 2026 | 43.21 | 43.69 | 42.65 | 42.66 | 607.60K |
| Sep 24, 2026 | 43.22 | 44.00 | 42.77 | 43.29 | 589.00K |
| Sep 23, 2026 | 43.66 | 44.46 | 43.14 | 43.39 | 544.50K |
| Sep 22, 2026 | 43.04 | 44.25 | 42.82 | 43.75 | 667.60K |
| Sep 21, 2026 | 42.00 | 42.97 | 41.68 | 42.78 | 635.70K |
About Supernus Pharmaceuticals
Supernus Pharmaceuticals (SUPN) is listed on the Nasdaq and classified by the SEC under βPharmaceutical Preparationsβ. Its business address is in ROCKVILLE, MD. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1356576.
SUPN board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Carrolee Barlow | Director | Feb 25, 2026 |
| Georges Gemayel | Director | Mar 9, 2026 |
| Frederick M. Hudson | Director | Mar 16, 2026 |
| Jack A. Khattar | President, CEO | Aug 14, 2026 |
| Charles W Iii Newhall | Director | Feb 25, 2026 |
| Bethany Sensenig | Director | Feb 23, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | Aug 14, 2026 |
| Timothy C Dec | Senior Vice-President & CFO | Aug 14, 2026 |
| William Todd Horich | SVP, Commercial Operations | Mar 10, 2026 |
| Jack A. Khattar | President, CEO | Aug 14, 2026 |
| Frank Mottola | SVP, Chief Tech. Ops. Officer | Aug 14, 2026 |
| Jonathan Rubin | SVP, Chief Medical Officer | Aug 14, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Mar 18, 2026 | Padmanabh P. Bhatt | Sale | 412 | $50.48 |
| Mar 18, 2026 | Padmanabh P. Bhatt | Sale | 6,838 | $49.55 |
| Mar 18, 2026 | Padmanabh P. Bhatt | Sale | 412 | $50.48 |
| Mar 18, 2026 | Padmanabh P. Bhatt | Sale | 6,838 | $49.55 |
| Mar 18, 2026 | Padmanabh P. Bhatt | Sale | 412 | $50.48 |
| Mar 18, 2026 | Padmanabh P. Bhatt | Sale | 6,838 | $49.55 |
| Mar 18, 2026 | Padmanabh P. Bhatt | Sale | 412 | $50.48 |
| Mar 18, 2026 | Padmanabh P. Bhatt | Sale | 6,838 | $49.55 |
| Mar 17, 2026 | Padmanabh P. Bhatt | Sale | 27,710 | $49.95 |
| Mar 17, 2026 | Padmanabh P. Bhatt | Sale | 22,290 | $50.73 |
| Mar 17, 2026 | Padmanabh P. Bhatt | Sale | 27,710 | $49.95 |
| Mar 17, 2026 | Padmanabh P. Bhatt | Sale | 22,290 | $50.73 |
| Mar 17, 2026 | Padmanabh P. Bhatt | Sale | 27,710 | $49.95 |
| Mar 17, 2026 | Padmanabh P. Bhatt | Sale | 22,290 | $50.73 |
| Mar 17, 2026 | Padmanabh P. Bhatt | Sale | 27,710 | $49.95 |
SUPN financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $718.95M | $-38.55M | -0.68 | $47.33M |
| Dec 31, 2024 | $661.82M | $73.86M | 1.32 | $171.95M |
| Dec 31, 2023 | $607.52M | $1.32M | 0.02 | $111.08M |
| Dec 31, 2022 | $667.24M | $60.71M | 1.04 | $116.83M |
| Dec 31, 2021 | $579.77M | $53.42M | 0.98 | $127.13M |
Latest balance sheet: total assets $1.43B, total liabilities $396.88M, cash $179.95M (as of Jun 30, 2026).
SUPN earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 3, 2026 | 8-K Item 2.02 (results) | $46.00 |
| Jul 22, 2026 | 8-K Item 2.02 (results) | $46.94 |
| May 5, 2026 | 8-K Item 2.02 (results) | $49.19 |
| Apr 22, 2026 | 8-K Item 2.02 (results) | $50.29 |
| Feb 24, 2026 | 8-K Item 2.02 (results) | $53.30 |
| Feb 12, 2026 | 8-K Item 2.02 (results) | $49.85 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $57.00 |
| Oct 21, 2025 | 8-K Item 2.02 (results) | $50.67 |
| Aug 5, 2025 | 8-K Item 2.02 (results) | $37.53 |
| Jul 22, 2025 | 8-K Item 2.02 (results) | $32.67 |
| May 6, 2025 | 8-K Item 2.02 (results) | $32.43 |
| Apr 23, 2025 | 8-K Item 2.02 (results) | $30.84 |
Related stocks Β· Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on SUPN
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.